Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T. Rowe Price Dividend Growth ETF | TDVG | Jan 29, 2025 | 41.22 | -0.15 |
T. Rowe Price Equity Income ETF | TEQI | Jan 29, 2025 | 42.44 | -0.04 |
T. Rowe Price Group | TROW | Jan 29, 2025 | 114.31 | -1.16 |
T. Rowe Price Growth Stock ETF | TGRW | Jan 29, 2025 | 40.84 | -0.71 |
T2 Biosystems | TTOO | Jan 29, 2025 | 0.22 | -4.35 |
Taboola.com | TBLA | Jan 29, 2025 | 3.81 | +3.81 |
Tactile Systems Technology | TCMD | Jan 29, 2025 | 17.89 | -0.56 |
Taitron Components A | TAIT | Jan 29, 2025 | 2.61 | +0.56 |
Taiwan Fund | TWN | Jan 29, 2025 | 38.12 | -0.47 |
Taiwan Index MSCI Ishares | EWT | Jan 29, 2025 | 51.08 | -0.20 |
Taiwan Semiconductor Manufacturing ADR | TSM | Jan 29, 2025 | 202.33 | -0.03 |
Take-Two Interactive Software | TTWO | Jan 29, 2025 | 190.09 | +1.58 |
Takeda Pharmaceutical ADR | TAK | Jan 29, 2025 | 13.31 | -0.45 |
TAL Education Group ADR | TAL | Jan 29, 2025 | 12.40 | -4.25 |
Talen Energy | TLN | Jan 29, 2025 | 214.00 | +4.69 |
Talkspace | TALK | Jan 29, 2025 | 3.18 | -0.63 |
Talos Energy | TALO | Jan 29, 2025 | 9.93 | 0.00 |
Talphera | TLPH | Jan 29, 2025 | 0.70 | -3.72 |
Tamboran Resources | TBN | Jan 29, 2025 | 24.70 | -0.60 |
Tandem Diabetes Care | TNDM | Jan 29, 2025 | 36.36 | -0.11 |
Tanger | SKT | Jan 29, 2025 | 32.77 | -1.21 |
Tango Therapeutics | TNGX | Jan 29, 2025 | 3.11 | -0.32 |
Tantech | TANH | Jan 29, 2025 | 0.15 | -10.95 |
Taoping | TAOP | Jan 29, 2025 | 0.27 | -1.59 |
Tapestry | TPR | Jan 29, 2025 | 74.39 | +0.81 |
Targa Resources | TRGP | Jan 29, 2025 | 202.86 | +0.24 |
Target | TGT | Jan 29, 2025 | 140.09 | -0.69 |
Target Hospitality | TH | Jan 29, 2025 | 9.88 | +6.07 |
Tarsus Pharmaceuticals | TARS | Jan 29, 2025 | 53.07 | +3.94 |
Taseko Mines | TGB | Jan 29, 2025 | 1.87 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.